Archives

by in
Entry Author Date Location
3 Life Sciences Companies That Are Built to Last 12/02/13 National
San Diego Venture Group Picks Three Finalists for Annual PitchFest 11/26/13 San Diego
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
San Diego Life Sciences Roundup: IPOs, CareFusion, and More 11/22/13 San Diego
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List 11/18/13 National
Pharmacyclics, J&J Win FDA Approval for Big Blood Cancer Drug 11/13/13 San Francisco
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
San Diego Life Sciences Roundup: Santarus, Cytori, IPOs, and More 11/08/13 San Diego
Arno, With Potential Suitor in Opko, Goes After Endometrial Cancer 11/06/13 New York
Karyopharm Prices Upsized IPO at $16 Per Share, Begins Trading Today 11/06/13 Boston
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’ 11/01/13 San Francisco
San Diego Life Sciences Roundup: Zogenix, Illumina, Sophiris, & More 11/01/13 San Diego
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Merrimack’s Cancer Drug Misses Mark in Mid-Stage Trial, Shares Tumble 10/30/13 Boston
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
Calithera BioSciences Nabs $35M for Cancer Drugs 10/29/13 San Francisco
Report: Dendreon Looking to Get Acquired 10/26/13 Seattle
San Diego Life Sciences Roundup: Illumina, Mirati, Auspex, and More 10/25/13 San Diego
Paul Hastings, Adelene Perkins Join Xconomy Biotech Event Dec. 9 10/25/13 San Francisco
San Diego’s Arcturus Raises $5M for “Best-in-Class” RNAi Technology 10/22/13 San Diego
VC Funding for Software Jumps in MoneyTree Report, and Top 10 Deals 10/18/13 National
San Diego Life Sciences Roundup: IPOs, Illumina, KFx Medical, & More 10/17/13 San Diego
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
Gilead Climbs on More Good News for Cancer Drug From Seattle 10/10/13 Seattle
San Diego Life Sciences Roundup: Tandem Diabetes, Ligand, and More 10/10/13 San Diego
San Diego’s PharmAkea Raises Capital, Forms Alliance with Celgene 10/07/13 San Diego
Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug 10/07/13 Boston
The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time 10/03/13 National
Page 4 of 55 « previous page · next page »